Daiichi Sankyo (Sankyo), a Japanese Pharmaceutical company, has agreed to pay $8.2 million to approximately 1,500 female sales representatives who claimed that they were discriminated against by receiving lower pay than their male counterparts in violation the Equal Pay Act, hereinafter referred to as the “Act.”
In 2013, Sara Wellens and five other sales representatives filed suit against Sankyo for violating Title VII, the California Fair Employment and Housing Act and the Act. The lawsuit alleged that Sankyo pays female sales employees less than male employees for doing the same work; promotes or advances female employees at a slower rate than male sales employees; treated pregnant employees and working mothers of young children adversely compared to non-pregnant employees, male employees, or non-caregivers; and discriminated against women in the workplace.
The suit was broken into two classes: California employed sales representatives over a four-year period and a similar group of women outside California. Payment under the settlement will be as follows: Sankyo will pay $3.7 million of the settlement to all of those women in proportion to how much they worked during the four-year period; and $926,200 to those Plaintiffs with claims for gender, pregnancy and caregiver discrimination. Sankyo also agreed to make changes to its employment policies and must hire an independent HR consultant. Of the settlement, $3 million will go to attorneys’ fees and costs as well as settlement administration and service payments to class representatives.
Larry Golson, a lawyer in our Consumer Fraud and Commercial Litigation Section, handles this type litigation for our firm. If you have been the victim of discriminatory pay practices, or have any questions about the subject, contact Larry at 800-898-2034 or email Larry.Golston@beasleyallen.com.